Dutasteride for the prevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia: results of a phase III randomized open-label 3-year trial
D Milonas, S Auskalnis, G Skulcius… - World journal of …, 2017 - Springer
Purpose High-grade prostatic intraepithelial neoplasia (HGPIN) is a potential precursor of
prostate cancer (PCa), and patients with HGPIN are at high risk for PCa development …
prostate cancer (PCa), and patients with HGPIN are at high risk for PCa development …
Dutasteride for the prevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia: results of a phase III randomized open-label 3-year trial
D Milonas, S Auskalnis, G Skulcius… - World Journal of …, 2016 - infona.pl
Purpose High-grade prostatic intraepithelial neoplasia (HGPIN) is a potential precursor of
prostate cancer (PCa), and patients with HGPIN are at high risk for PCa development …
prostate cancer (PCa), and patients with HGPIN are at high risk for PCa development …
Dutasteride for the prevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia: results of a phase III randomized open-label 3-year trial.
D Milonas, S Auskalnis, G Skulcius… - World Journal of …, 2017 - search.ebscohost.com
Purpose: High-grade prostatic intraepithelial neoplasia (HGPIN) is a potential precursor of
prostate cancer (PCa), and patients with HGPIN are at high risk for PCa development …
prostate cancer (PCa), and patients with HGPIN are at high risk for PCa development …
Dutasteride for the prevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia: results of a phase III randomized open-label 3-year trial
D Milonas, S Auskalnis, G Skulcius… - World Journal of …, 2017 - search.proquest.com
Purpose High-grade prostatic intraepithelial neoplasia (HGPIN) is a potential precursor of
prostate cancer (PCa), and patients with HGPIN are at high risk for PCa development …
prostate cancer (PCa), and patients with HGPIN are at high risk for PCa development …
Dutasteride for the prevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia: results of a phase III randomized open-label 3-year trial.
D Milonas, S Auskalnis, G Skulcius… - World Journal of …, 2016 - europepmc.org
Purpose High-grade prostatic intraepithelial neoplasia (HGPIN) is a potential precursor of
prostate cancer (PCa), and patients with HGPIN are at high risk for PCa development …
prostate cancer (PCa), and patients with HGPIN are at high risk for PCa development …
Dutasteride for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: Results of phase III randomized open label trial/D. Milonas …
D Milonas, G Skulčius, S Auškalnis, M Kinčius… - … 2014, vol. 13, iss. 1, April …, 2014 - lsmu.lt
Introduction & objectives: Prostate cancer (PCa) prevention remains an appealing strategy
for the reduction of overtreatment and secondary adverse events after radical treatment. We …
for the reduction of overtreatment and secondary adverse events after radical treatment. We …
Dutasteride for the prevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia: results of a phase III randomized open-label 3-year trial
D Milonas, S Auskalnis, G Skulcius… - World journal of …, 2017 - pubmed.ncbi.nlm.nih.gov
Purpose High-grade prostatic intraepithelial neoplasia (HGPIN) is a potential precursor of
prostate cancer (PCa), and patients with HGPIN are at high risk for PCa development …
prostate cancer (PCa), and patients with HGPIN are at high risk for PCa development …
Dutasteride for the prevention of prostate cancer in men with high‑grade prostatic intraepithelial neoplasia: results of a phase III randomized open‑label 3‑year trial
D Milonas, S Auškalnis, G Skulčius… - World journal of urology …, 2017 - lsmu.lt
PURPOSE: High-grade prostatic intraepithelial neoplasia (HGPIN) is a potential precursor of
prostate cancer (PCa), and patients with HGPIN are at high risk for PCa development …
prostate cancer (PCa), and patients with HGPIN are at high risk for PCa development …